Terms: = Liver cancer AND FCGR2B, FCGR2, 2213, ENSG00000072694, CD32, CD32B, P31994, IGFR2, FCG2 AND Prognosis
4 results:
1. Prognostic impact of splenic vessel involvement and tumor size in distal pancreatectomy for adenocarcinoma: a retrospective multicentric cohort study.
Gantois D; Guilbaud T; Scemama U; Girard E; Picaud O; Lefevre M; Elgani M; Hamidou Z; Moutardier V; Balandraud P; Chirica M; Barbier L; Fuks D; Birnbaum DJ
Langenbecks Arch Surg; 2022 Feb; 407(1):153-165. PubMed ID: 34373941
[TBL] [Abstract] [Full Text] [Related]
2. Development of an immune-related prognostic index associated with hepatocellular carcinoma.
Hu B; Yang XB; Sang XT
Aging (Albany NY); 2020 Mar; 12(6):5010-5030. PubMed ID: 32191631
[TBL] [Abstract] [Full Text] [Related]
3. Optimal cut points for quality of life questionnaire-core 30 (QLQ-C30) scales: utility for clinical trials and updates of prognostic systems in advanced hepatocellular carcinoma.
Diouf M; Bonnetain F; Barbare JC; Bouché O; Dahan L; Paoletti X; Filleron T
Oncologist; 2015 Jan; 20(1):62-71. PubMed ID: 25542450
[TBL] [Abstract] [Full Text] [Related]
4. Serum manganese superoxide dismutase and thioredoxin are potential prognostic markers for hepatitis C virus-related hepatocellular carcinoma.
Tamai T; Uto H; Takami Y; Oda K; Saishoji A; Hashiguchi M; Kumagai K; Kure T; Mawatari S; Moriuchi A; Oketani M; Ido A; Tsubouchi H
World J Gastroenterol; 2011 Nov; 17(44):4890-8. PubMed ID: 22171130
[TBL] [Abstract] [Full Text] [Related]
